Skip to main content
OpenTrials

Clinical trial condition

Autosomal Recessive Polycystic Kidney (ARPKD)

Explore clinical trials studying Autosomal Recessive Polycystic Kidney (ARPKD). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Autosomal Recessive Polycystic Kidney (ARPKD) trial results

Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

NCT04782258

Conditions
Abnormalities, Multiple, Autosomal Recessive Polycystic Kidney (ARPKD), Ciliopathies, +14 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology Chicago, Illinois, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View all 23 locations
View Trial Details

Related conditions